Skip to content
    Vickers Venture Partners logo

    Vickers Venture Partners

    SingaporeFounded 2005
    www.vickersventure.comLinkedIn
    Biotech & Life SciencesHealthcareAIClimate & EnergyEnterprise SoftwareFintechMedia & EntertainmentTelecomConsumerEducationGamingFood & AgricultureMobility & TransportationPropTechCybersecurityTravel & Hospitality

    Vickers Venture Partners is a Singapore-headquartered global venture capital firm focused on early-stage deep tech investments across the United States, China, India, and beyond. The firm backs entrepreneurs with revolutionary technologies committed to solving major global problems across sectors including life sciences, AI, clean energy, and more.

    Average disclosed round size is $49.4M (across 37 rounds with reported amounts).

    Find people at Vickers Venture Partners on Goldilocks AI

    Portfolio

    23

    Fund Size

    $255M

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    Mr. Wei Luo

    Mr. Wei Luo

    Assistant Managing Director

    Mr. Joo Seng Wong

    Mr. Joo Seng Wong

    Venture Partner

    Mr. Naveen Pralhad Deshpande

    Mr. Naveen Pralhad Deshpande

    Venture Partner

    Mr. Raveederen Ramamoothie

    Mr. Raveederen Ramamoothie

    Venture Partner

    Mr. Vadim Shpak

    Mr. Vadim Shpak

    Venture Partner

    ML

    Ms. Linda Li

    Venture Partner

    Dr. Poh Hui Chia

    Dr. Poh Hui Chia

    Director

    Mr. Kar Hoe Lum

    Mr. Kar Hoe Lum

    Director, Finance

    Mr. Joel Shen

    Mr. Joel Shen

    Venture Principal

    Bernice Tan

    Bernice Tan

    Executive Assistant

    Dr Finian Tan

    Dr Finian Tan

    Chairman, CIO

    Dr Jeffrey Chi

    Dr Jeffrey Chi

    co-founders

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    41 investments
    CompanyRoundAmountDate
    Aardvark logoAardvarkSeries C$85MMay 2024
    Aardvark Therapeutics logoAardvark TherapeuticsSeries C$85MMay 2024
    HyperAccel logoHyperAccelSeries A—Jan 2024
    Eavor logoEavorGrowth$182MOct 2023
    AAWAK TechnologiesSeries B—Sep 2023
    Eavor logoEavorSeries B$40MJan 2023
    Aardvark Therapeutics logoAardvark TherapeuticsSeries B$29MAug 2021
    Aardvark logoAardvarkSeries B$29MAug 2021
    Aardvark logoAardvarkSeries B$29MJan 2021
    SSisafSeries B$13.2MNov 2020
    Chooch logoChoochSeries A$20MNov 2020
    CChooch AISeries A$20MNov 2020
    Matchmove logoMatchmoveUnknown$21MSep 2020
    MMatchmove Pay Pte LtdUnknown$21MSep 2020
    RRWDCSeries B$133MMay 2020
    RRWDC Industries LimitedSeries B$133MMay 2020
    EEmergex Vaccines Holding LimitedSeries A$11MJan 2020
    RRWDCSeries B$133MJan 2020
    SSisafSeries B$13.2MJan 2020
    Lumitron logoLumitronUnknown$34MJan 2020
    CChooch AISeries A$20MJan 2020
    AAWAK TechnologiesSeries A$40MDec 2019
    Everledger logoEverledgerSeries A$20MSep 2019
    Eavor logoEavorSeries A$15MSep 2019
    CChooch AISeed$2.8MJan 2019
    Page 1 of 2

    Top Co-Investors

    Alumni Ventures5 shared
    SEEDS Capital5 shared
    Temasek Holdings (Private) Limited5 shared
    private angel investors4 shared
    Cormorant Asset Management4 shared
    2123 shared
    Streamlined Ventures3 shared
    Advanced MedTech3 shared
    Premier Partners3 shared
    Felicis3 shared
    British Business Bank3 shared
    Japan Energy Fund2 shared
    BDC Capital2 shared
    bp ventures2 shared
    Microsoft Climate Innovation Fund2 shared
    Decheng Capital2 shared
    LG Technology Ventures2 shared
    SymBiosis2 shared
    Surveyor Capital2 shared
    Endeavor2 shared

    Last updated: 20 October 2026